Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus is a research paper published in Journal of the American Academy of Dermatology (2020). On theSindex it has a DataRank of 0.515. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.515
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: K24-AR02207
National Institutes of Health
Grant: R01AR071653
NIAMS NIH HHS
Grant: K24 AR002207
National Institutes of Health
Grant: 5K24AR002207-09
Patient-oriented research in skin autoimmune disease
National Institutes of Health
Grant: 5R01AR071653-03
Optimization of Clinical Trial Design in Cutaneous Lupus
U.S. Department of Veterans Affairs
Biomedical Laboratory Research and Development, VA Office of Research and Development
Health Services Research and Development
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals